New Drugs Join Alcohol-Abuse Arsenal A Look at Current Drugs to Treat Alcoholism
Posted on: Monday, 26 September 2005, 15:00 CDT
The three federally approved treatments for alcohol abuse, and one medication under consideration for approval:
ANTABUSE: A decades-old aversion therapy drug designed to discourage drinking by making users sick if they drink alcohol.
NALTREXONE: A generic medication that can block the brain chemicals that make addicts feel good after drinking or taking drugs like heroin. Approved as an alcohol-abuse treatment in 1994.
CAMPRAL: The U.S. trade name for a medication used for nearly two decades in Europe and other countries, where it is known as acamprosate. Campral, marketed in the United States by Forest Laboratories Inc., is designed to help recovering alcoholics stay abstinent by easing withdrawal symptoms and reversing drinking- induced brain chemistry imbalances.
VIVITREX: A reformulated, long-acting version of naltrexone administered by injection once a month in a doctor's office to slowly release the drug. Vivitrex's maker, Alkermes Inc., believes many alcoholics will find it easier to stick to the once-a-month regimen than naltrexone users' daily pill-taking routine. The Food and Drug Administration is expected to respond by Friday to Alkermes' request to market the drug.
Source: Advocate; Baton Rouge, La.
Related Articles
- A Comprehensive Analysis of the Alcoholic Drinks Market in Iran, Providing a Valuable Overview of the Current Industry Environment
- An Analysis of the Alcoholic Drinks Industry in Azerbaijan, Including Market Trends, Product Segmentation & Leading Companies
- The Value of the European and US Alcoholic Drinks Market Combined is Expected to Reach $745.1bn By 2010
- Injectable Drug to Help Alcoholics Stay Sober Hits the Market
- Alcoholic Drinks in China - A Market Analysis
- Global Alcohol Drink Trends
- Study focuses on age of first alcoholic drink
- Boon Rawd to Push Non-Alcoholic Drinks
- Epilepsy Drug May Fight Alcoholism
 |
 |
User Comments (0)
RSS Feeds